2 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 2, Recruiting 2, Active not recruiting 1, Terminated 1 |
Follow SGLT-2 inhibitor: new trials by email Literature Review of SGLT-2 inhibitor trials Research Report on SGLT-2 inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study Sacubitril / Valsartan, SGLT-2 inhibitor, SGLT2 Inhibition - Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy | Phase 4 | Recruiting | Kyungsub Song | 80 | 2026-05-20 | 2026-09-02 |
| SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients SGLT-2 inhibitor, Placebo - Kidney Transplantation Recipients, Sodium-Glucose Transporter 2 Inhibitors | Phase 4 | Recruiting | Odense University Hospital | 88 | 2025-09-01 | 2025-08-27 |
| Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With Metabolic Syndrome Tadalafil 5 mg, SGLT-2 inhibitor, Tadalafil plus SGLT2 inhibitors - Erectile Dysfunction, Left Ventricular Diastolic Dysfunction | Phase 4 | Completed | Kafrelsheikh University | 60 | 2025-05-05 | 2026-05-04 |
| Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists SGLT-2 inhibitor, GLP1-RA - Type 2 Diabetes (T2DM) | Phase 4 | Active not recruiting | MaryAnn Banerji | 60 | 2024-12-21 | 2026-01-08 |
| SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency SGLT-2 inhibitor - Heart Failure With Reduced Ejection Fraction, Renal Insufficiency, Chronic | Phase 4 | Terminated | Peking University People's Hospital | 11 | 2023-03-09 | 2024-04-30 |
| SGLT2i and Incretin and CRTd. Incretin Effect, Cardiac Resynchronization therapy defibrillator device, SGLT-2 inhibitor - Type 2 Diabetes Mellitus, Heart Failure | Phase 4 | Completed | University of Campania Luigi Vanvitelli | 500 | 2017-09-01 | 2025-06-25 |
Diabetes Mellitus, Type 2 (2) · Heart Failure (2) · Erectile Dysfunction (1) · Heart Valve Diseases (1) · Metabolic Syndrome (1) · Renal Insufficiency, Chronic (1) · Ventricular Dysfunction, Left (1)
Kafrelsheikh University (1) · Kyungsub Song (1) · MaryAnn Banerji (1) · Odense University Hospital (1) · Peking University People's Hospital (1) · University of Campania Luigi Vanvitelli (1)
China (1) · Denmark (1) · Egypt (1) · Italy (1) · South Korea (1) · United States (1)
Kyungsub Song, MD (1) · Lotte B Lange, MD (1) · Mary Ann Banerji, MD (1) · Mohamed G Abdelraouf, MD (1) · Reda B Bastawisy, MD (Professor) (1) · Wael A Haseeb, MD (Assistant professor) (1)